Active clearance of human amyloid β 1-42 peptide aggregates from the rat ventricular system

Yasushi Nakagawa, Takefumi Yuzuriha, Toru Iwaki

研究成果: Contribution to journalArticle査読

7 被引用数 (Scopus)

抄録

A major constituent of SP in the brains of Alzheimer's disease is 39-43 amino acid peptide called β-amyloid peptide (Aβ). Recent data have demonstrated that Aβ has a strong tendency to form insoluble aggregates and that toxic effects of Aβ is based on its aggregation. In the current study, 100 μg of human synthetic Aβ 1-42 (sAβ 1-42) was infused into the lateral ventricle of rat brain using a short-term infusion model. At 2 or 7 days following the infusion, sAβ 1-42 was found to form insoluble aggregates, scattering throughout the entire ventricular systems. The sAβ 1-42 aggregates were partially engulfed by phagocytic cells and deposited at the meningeal vessels or the choroid plexuses. However, these deposits mostly disappeared from the ventricles by 28 days post-infusion. Here, it is reported for the first time that considerable amounts of sAβ 1-42 are almost cleared from the rat ventricular system by the mononuclear phagocytic system.

本文言語英語
ページ(範囲)194-200
ページ数7
ジャーナルNeuropathology
24
3
DOI
出版ステータス出版済み - 9 2004

All Science Journal Classification (ASJC) codes

  • 病理学および法医学
  • 臨床神経学

フィンガープリント

「Active clearance of human amyloid β 1-42 peptide aggregates from the rat ventricular system」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル